GSWM
FLNA

Golden State Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Golden State Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43 Hold
36
– – ﹤0.01% 1597
2026
Q1 		$61 Hold
36
– – ﹤0.01% 1577
2025
Q4 		$71 Hold
36
– – ﹤0.01% 1651
2025
Q3 		$105 Hold
36
– – ﹤0.01% 1631
2025
Q2 		$65 Hold
36
– – ﹤0.01% 1554
2025
Q1 		$54 Hold
36
– – ﹤0.01% 1574
2024
Q4 		$85 Buy
+36
New +$632 ﹤0.01% 1490

Other funds holding FLNA

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Golden State Wealth Management's FLNA Position: Q2 2026 in Review

Golden State Wealth Management held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 36 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Golden State Wealth Management first reported a position in FLNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $105 in Q3 2025. 15 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Golden State Wealth Management held 36 shares of Filana Therapeutics worth $43 as of Q2 2026.
  • Golden State Wealth Management left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1597 holding.
  • Golden State Wealth Management first reported a position in Filana Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Golden State Wealth Management's Filana Therapeutics position peaked at $105 in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.